Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients.